Compare ZURA & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | CWCO |
|---|---|---|
| Founded | 2022 | 1973 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 464.1M |
| IPO Year | 2021 | 1997 |
| Metric | ZURA | CWCO |
|---|---|---|
| Price | $4.09 | $30.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 73.0K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $132,073,368.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $47.61 |
| P/E Ratio | ★ N/A | $63.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.15 | $27.23 |
| 52 Week High | $7.25 | $39.12 |
| Indicator | ZURA | CWCO |
|---|---|---|
| Relative Strength Index (RSI) | 36.17 | 69.50 |
| Support Level | $3.90 | $28.90 |
| Resistance Level | $5.87 | $33.61 |
| Average True Range (ATR) | 0.29 | 0.75 |
| MACD | 0.03 | 0.33 |
| Stochastic Oscillator | 34.37 | 94.56 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.